Vita means life. It's also our platform for sharing the stories of biotech's promise to patients and public health.
CSL consists of CSL Behring, CSL Seqirus and CSL Vifor. Learn more by visiting each section.
Biotechnology leader CSL Behring offers the broadest range of quality plasma-derived and recombinant therapies in our industry.
Derived from the expression 'securing health for all of us', CSL Seqirus is one of the world's largest influenza vaccine providers.
R&D focuses its expertise on four strategic platforms: plasma protein technology; recombinant technology; cell and gene therapy; and vaccines technology.
One of our core values at CSL is Innovation. We support collaborative innovation through the endowment of awards and grants to researchers around the world.
As part of our broader sustainability strategy to build a more sustainable future, we've committed to a 40% reduction in absolute Scope 1 and 2 emissions by 2030.
Along with our sustainability strategy, CSL’s community contribution framework helps deliver on our Values and support execution of our 2030 strategy.
At CSL, Diversity, Equity, and Inclusion (DEI) is at the core of our mission and who we are. It fuels our innovation day in and day out.
Whether you are early in your college education or recently completed your degree, it's never too soon to consider CSL for your Promising Future!
Research found slightly more than half of HAE patients who had COVID-19 experienced a swelling attack while infected.
She’s a team-focused Aussie scientist working on early-stage potential medicines and driven by CSL’s promise to patients. At …
The story behind a partnership improving access to antivenoms and saving lives in Papua New Guinea.
When should you consult a doctor? Find out in this infographic.
Debbie Drane, Senior Vice President of Commercial Development, moderates a panel on patient access to innovative treatments l…
Filmed at 30 locations around the world during the global pandemic, the “anthem” explains why global biotech CSL is driven by…
You’re on a first date. Should you or shouldn’t you tell them about your serious medical condition? We have advice from two r…
Our constantly curious Senior Director for Bulk Manufacturing says she’s driven by CSL’s promise to patients and energized by…
The Patients As Partners Conference, coming to Philadelphia next month, is living up to its name by offering 20 spots to pati…
Americas
Asia Pacific
Middle East
Europe